Dr.med. Irina Bergamin
Gastroenterology/Hepatology · Dept. I
STAR LIGHT Study: XBB.1.5 COVID-19 mRNA Vaccines Boost Systemic but Not Mucosal Immunity Against the SARS-CoV-2 JN.1 Variant in Patients with Chronic Liver Disease.
Woelfel S, Junker D, Bergamin I, Meyer-Herbon P, Stillhard R, Graf N, Leinenkugel G, Dütschler J, König M, Häuptle R, Zwyssig S, Krieger-Grübel C, Truniger S, Koller S, Metzger-Peter K, Frei N, Genetics And Observational Subarachnoid Haemorrhage Gosh Study Investigators, Albrich W, Friedrich M, Bernsmeier C, Niess J, Korte W, Bürgi J, Dulovic A, Schneiderhan-Marra N, Semela D, Brand S. STAR LIGHT Study: XBB.1.5 COVID-19 mRNA Vaccines Boost Systemic but Not Mucosal Immunity Against the SARS-CoV-2 JN.1 Variant in Patients with Chronic Liver Disease. Vaccines (Basel) 2024; 12
Oct 31, 2024STAR LIGHT Study: XBB.1.5 COVID-19 mRNA Vaccines Boost Systemic but Not Mucosal Immunity Against the SARS-CoV-2 JN.1 Variant in Patients with Chronic Liver Disease.
Oct 31, 2024Vaccines (Basel) 2024; 12
Woelfel Simon, Junker Daniel, Bergamin Irina, Meyer-Herbon Pamela, Stillhard Roman, Graf Nicole, Leinenkugel Georg, Dütschler Joel, König Marius, Häuptle Rahel, Zwyssig Sarah, Krieger-Grübel Claudia, Truniger Samuel, Koller Seraina, Metzger-Peter Katline, Frei Nicola Fabian, Genetics And Observational Subarachnoid Haemorrhage Gosh Study Investigators, Albrich Werner, Friedrich Matthias, Bernsmeier Christine, Niess Jan-Hendrik, Korte Wolfgang C, Bürgi Justus J, Dulovic Alex, Schneiderhan-Marra Nicole, Semela David, Brand Stephan
Presence of autoantibodies in serum does not impact the occurrence of immune checkpoint inhibitor-induced hepatitis in a prospective cohort of cancer patients.
Purde M, Niederer R, Wagner N, Diem S, Berner F, Hasan Ali O, Hillmann D, Bergamin I, Jörger M, Risch M, Niederhauser C, Lenz T, Früh M, Risch L, Semela D, Flatz L. Presence of autoantibodies in serum does not impact the occurrence of immune checkpoint inhibitor-induced hepatitis in a prospective cohort of cancer patients. J Cancer Res Clin Oncol 2021; 148:647-656.
Dec 7, 2021Presence of autoantibodies in serum does not impact the occurrence of immune checkpoint inhibitor-induced hepatitis in a prospective cohort of cancer patients.
Dec 7, 2021J Cancer Res Clin Oncol 2021; 148:647-656
Purde Mette-Triin, Niederer Rebekka, Wagner Nikolaus, Diem Stefan, Berner Fiamma, Hasan Ali Omar, Hillmann Dorothea, Bergamin Irina, Jörger Markus, Risch Martin, Niederhauser Christoph, Lenz Tobias L, Früh Martin, Risch Lorenz, Semela David, Flatz Lukas
Klinisches Management von Patienten mit Leberzirrhose
Bergamin I, Meyer-Herbon P, Künzler-Heule P, Semela D. Klinisches Management von Patienten mit Leberzirrhose. Schweiz. Gastroenterol. 2021
Dec 3, 2021Klinisches Management von Patienten mit Leberzirrhose
Dec 3, 2021Schweiz. Gastroenterol. 2021
Bergamin Irina, Meyer-Herbon Pamela, Künzler-Heule Patrizia, Semela David
Bauchschmerzen bei viralem Infekt sind nicht immer trivial
Minotti B, Bergamin I, von Ow D. Bauchschmerzen bei viralem Infekt sind nicht immer trivial. Praxis 2021; 110:449-451.
Jun 10, 2021Bauchschmerzen bei viralem Infekt sind nicht immer trivial
Jun 10, 2021Praxis 2021; 110:449-451
Minotti Bruno, Bergamin Irina, von Ow Dieter
[Abdominal Pain Caused by Viral Infection Is Not Always Trivial]
Minotti B, Bergamin I, von Ow D. [Abdominal Pain Caused by Viral Infection Is Not Always Trivial]. Praxis (Bern 1994) 2021; 110:449-451.
Jun 1, 2021[Abdominal Pain Caused by Viral Infection Is Not Always Trivial]
Jun 1, 2021Praxis (Bern 1994) 2021; 110:449-451
Minotti Bruno, Bergamin Irina, von Ow Dieter
Sonografische Wandveränderungen der steinfreien Gallenblase – ein diagnostisches und therapeutisches Dilemma
Urban M, Bergamin I, Osterwalder J. Sonografische Wandveränderungen der steinfreien Gallenblase – ein diagnostisches und therapeutisches Dilemma. Praxis 2021; 110:1-4.
Feb 1, 2021Sonografische Wandveränderungen der steinfreien Gallenblase – ein diagnostisches und therapeutisches Dilemma
Feb 1, 2021Praxis 2021; 110:1-4
Urban Max, Bergamin Irina, Osterwalder Joseph
Hepatosplenische Schistosomasis
Seidl S, Bergamin I, Boggian K, Meuthen T. Hepatosplenische Schistosomasis. Swiss Medical Forum 2019; 19:824-826.
Dec 4, 2019Hepatosplenische Schistosomasis
Dec 4, 2019Swiss Medical Forum 2019; 19:824-826
Seidl Sebastian, Bergamin Irina, Boggian Katia, Meuthen Thorsten
Controlled attenuation parameter for the assessment of liver steatosis in comparison with liver histology: a single-centre real life experience
Baumeler S, Jochum W, Neuweiler J, Bergamin I, Semela D. Controlled attenuation parameter for the assessment of liver steatosis in comparison with liver histology: a single-centre real life experience. Swiss Med Wkly 2019; 149:w20077.
Apr 26, 2019Controlled attenuation parameter for the assessment of liver steatosis in comparison with liver histology: a single-centre real life experience
Apr 26, 2019Swiss Med Wkly 2019; 149:w20077
Baumeler Stephan, Jochum Wolfram, Neuweiler Jörg, Bergamin Irina, Semela David
Excellent outcome of direct antiviral treatment for chronic hepatitis C in Switzerland
Bachofner J, Mertens J, Terziroli Beretta-Piccoli B, Mullhaupt B, Magenta L, Semela D, Fehr J, Moncsek A, Seifert B, Braun D, Baserga A, Künzler-Heule P, Kröger A, Bergamin I, Valli P, The Swiss Hepatitis C Cohort Study. Excellent outcome of direct antiviral treatment for chronic hepatitis C in Switzerland. Swiss Med Wkly 2018; 148:w14560.
Jan 18, 2018Excellent outcome of direct antiviral treatment for chronic hepatitis C in Switzerland
Jan 18, 2018Swiss Med Wkly 2018; 148:w14560
Bachofner Jacqueline, Mertens Joachim, Terziroli Beretta-Piccoli Benedetta, Mullhaupt Beat, Magenta Lorenzo, Semela David, Fehr Jan, Moncsek Anja, Seifert Burkhardt, Braun Dominique L, Baserga Adriana, Künzler-Heule Patrizia, Kröger Arne, Bergamin Irina, Valli Piero V, The Swiss Hepatitis C Cohort Study
DAA treatment of chronic hepatitis C results in rapid regression of transient elastography and fibrosis markers FIB-4 and APRI
Bachofner J, Mullhaupt B, Terziroli Beretta-Piccoli B, Magenta L, Semela D, Fehr J, Moncsek A, Seifert B, Braun D, Baserga A, Künzler-Heule P, Bergamin I, Kröger A, Valli P, Mertens J. DAA treatment of chronic hepatitis C results in rapid regression of transient elastography and fibrosis markers FIB-4 and APRI. Liver Int 2016
Sep 28, 2016DAA treatment of chronic hepatitis C results in rapid regression of transient elastography and fibrosis markers FIB-4 and APRI
Sep 28, 2016Liver Int 2016
Bachofner Jacqueline A, Mullhaupt Beat, Terziroli Beretta-Piccoli Benedetta, Magenta Lorenzo, Semela David, Fehr Jan, Moncsek Anja, Seifert Burkhardt, Braun Dominique, Baserga Adriana, Künzler-Heule Patrizia, Bergamin Irina, Kröger Arne, Valli Piero V, Mertens Joachim C